Loading insider details...
Latest Form 4 (Jul 29, 2026): Sale of 1,100 MLTX shares, $22.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 1,100 | $22.0K |
| Jul 23, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 50,000 | $1.00M |
| Jul 21, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 43,700 | $877.9K |
| Jul 20, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 16,105 | $322.3K |
| Jun 17, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 50,000 | $944.5K |
| Jan 9, 2026 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 520,342 | n/a |
| Dec 22, 2025 | MoonLake Immunotherapeutics (MLTX) | Conversion | 35,389 | n/a |
| Dec 10, 2025 | MoonLake Immunotherapeutics (MLTX) | Sale | 130,000 | $1.96M |
| Sep 4, 2025 | MoonLake Immunotherapeutics (MLTX) | Conversion | 48,978 | n/a |
| Mar 4, 2025 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 139,273 | n/a |